Site Newsletter

Press Release

Biohit Oyj B-shares Subscribed with Stock Options I 2013

Posted on: 12 Mar 18

Biohit Oyj Stock Exchange Release July 5, 2018 at 09:30 a.m. (EEST)

A total number of 10,054 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 7 February 2018 and 4 June 2018. These shares have been entered into the Trade Register on July 2, 2018, as of which date the new shares will establish equal shareholder rights with the company's existing B-shares. Public trading begins on NASDAQ Helsinki as of July 3, 2018 together with the existing B-shares.

The share subscription price was EUR 2.2766 per share respectively. The entire subscription price of EUR 22,888.94 will be credited to the reserve for invested non-restricted equity, and the company share capital remains unchanged. The shares have no nominal value.

After the subscriptions the number of all Biohit Oyj's shares will rise to 14,899,332 shares and B-shares will rise to 11,923,832 shares.

The share subscription period with stock options I 2013 began on June 1, 2015 and will end May 31, 2019.The option schemes are based on the Biohit Oyj board resolution of June 19, 2013 and the Annual General Meeting authorization of April 13, 2011. The terms and conditions of the option schemes with additional information are available on Biohit Oyj website at www.biohithealthcare.com.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her
physician.